Previous studies suggested that α-SMA-positive CAFs became enriched into rectal cancer following neoadjuvant therapy and were correlated with poor prognosis represented by shortened recurrence-free survival 48, 49. The gene discussed is ACTA1; the disease is rectal cancer.